Exploratory Clinical Study of MT-2301 in Healthy Infants (Phase 2)
Phase of Trial: Phase II
Latest Information Update: 24 Oct 2015
At a glance
- Drugs Haemophilus b CRM197 conjugate vaccine (HibTITER) (Primary) ; DTP poliovirus vaccine; Hib vaccine conjugate
- Indications Haemophilus infections
- Focus Pharmacodynamics
- Sponsors Mitsubishi Tanabe Pharma Corporation
- 16 Oct 2015 Status changed from active, no longer recruiting to completed, as reported by ClinicalTrials.gov.
- 08 Oct 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 09 Jul 2014 New trial record